Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 7:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 2,192 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: POINT Clear all

Conditions: Sickle Cell Disease (SCD)
Interventions: Verum Acupressure (using AcuWand), Sham Acupressure (using AcuWand); Device
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2033
U.S. locations: 2
States / cities: Irvine, California • Cincinnati, Ohio

Conditions: Anesthesia
Interventions: Artificial Intelligence-assisted Point-of-Care Echocardiography; Diagnostic Test
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Solid Tumor, Adult
Interventions: Fludeoxyglucose F 18, Positron Emission Tomography, Computerized Tomography, Magnetic Resonance Imaging; Radiation · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cardiovascular Disease, Periodontal Disease
Interventions: Early Periodontal Treatment, Usual Dental Hygiene; Procedure
Lead sponsor: Boston University; Other
Eligibility: 20 Years and older
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Influenza-Like Illness, Influenza
Interventions: Core Lab Test, ED Point of Care Test; Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 233 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer, Cancer Metastatic, BRAF V600E, MEK1 Gene Mutation, MEK2 Gene Mutation, ERK Mutation, RAF1 Gene Mutation
Interventions: Abemaciclib, LY3214996; Drug
Lead sponsor: Anita Turk; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Hepatitis C
Interventions: Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid); Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Takayasu's Arteritis, Giant Cell Arteritis
Interventions: Abatacept, Placebo; Drug
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 15 Years and older
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 8
States / cities: Los Angeles, California • Baltimore, Maryland • Boston, Massachusetts + 5 more

Conditions: Keloid, Keloid Scar Following Surgery
Interventions: Triamcinolone Injection, Triamcinolone Injection and 5-fluorouracil injection; Drug
Lead sponsor: Our Lady of the Lake Hospital; Other
Eligibility: Not listed
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Tricuspid Regurgitation, Mechanical Ventilation Pressure High, Pediatric Respiratory Diseases
Interventions: Application of positive-end-expiratory pressure; Other
Lead sponsor: Northwell Health; Other
Eligibility: 3 Months to 18 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Vulvar Intraepithelial Neoplasia, HPV-Independent, Vulvar Squamous Cell Carcinoma, Vulvar Squamous Intraepithelial Lesion, HPV-Associated
Interventions: Non-Interventional Study; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: COVID-19, Upper Respiratory Infection, Lower Respiratory Infection
Interventions: Fitbit, Douglas Bag, Periflux 6000 EPOS, BIOPAC, Flowmet, NIRS; Device
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 78 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Maternal Psychological Distress, Perinatal Depression, Self-Regulation, Emotion
Interventions: Trauma Informed Prenatal Intervention (TPI), Prenatal Education Topics; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Kidney Transplant Failure and Rejection
Interventions: AlloSure ddcfDNA assay, AlloMap assay, Inflammatory Cytokines, Immune Cell Phenotypes; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 75 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Hamstring Contractures, Muscle Tightness
Interventions: Hypervolt, Body Tempering, Dry cupping, Static stretching; Device · Other
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years to 39 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Cognitive Impairment, Mild
Interventions: Telerehabilitation Experimental Group, Telerehabilitation Sham Control Group; Device · Other
Lead sponsor: Bright Cloud International Corp; Industry
Eligibility: 20 Years to 65 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 2
States / cities: New Brunswick, New Jersey • North Brunswick, New Jersey

Conditions: Assault by Handgun Discharge, Violence, Homicide, Sexual Assault by Bodily Force, Substance Abuse Problem
Interventions: Lithium Water, placebo: spring mineral water, natural spring water; Dietary Supplement · Other
Lead sponsor: American Society Of Thermalism And Climatology Inc; Other
Eligibility: 14 Years to 60 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Arterial Occlusion, Cardiovascular Diseases, Atherosclerosis, Hematoma
Interventions: Perclose, Statseal; Device · Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Respiratory Tract Infections, Influenza, Human, Common Cold
Interventions: Rapid respiratory pathogen nucleic acid amplification test; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 1 Year to 101 Years
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Covid19
Interventions: Onsite Point-of-care; Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Long Island City, New York • The Bronx, New York

Conditions: Catastrophizing Pain
Interventions: Midazolam and Fentanyl, Educational Reassurance; Drug · Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Suicide Ideation, Depression, Family Conflict
Interventions: Attachment Based Family Therapy, Enhanced Usual Care; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 12 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Critical Illness
Interventions: Ultrasound; Diagnostic Test
Lead sponsor: Joseph D. Tobias; Other
Eligibility: Up to 18 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Influenza, Respiratory Viral Infection
Interventions: Point-of-care molecular testing and treatment of influenza; Combination Product
Lead sponsor: University of Washington; Other
Eligibility: 3 Months and older
Enrollment: 1,618 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 9
States / cities: Burien, Washington • Seattle, Washington

Search by objective public record fields.

Self-administered Acupressure in Patients With Sickle Cell Disease

Assessment of Diagnostic Adequacy of AI-assisted Point-of-Care Echocardiography Among Anesthesiology Trainees

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Impact of Gum Infection on Heart Disease

Impact of Rapid Flu Testing in BMC ED

A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.

ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids

Effect of PEEP on TRJV in Mechanically Intubated Pediatric Patients

Evaluation of a Point-of-Care, AI-Powered Spectroscopy Device for Triage of Suspicious Vulvar Lesions: A Pilot Study

A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases

Reducing Stress-Sensitive Problems Among Pregnant Black Women With Childhood Adversity

AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation

Immediate and 24-hour Effects of HyperVolt, Body Tempering, and Cupping Compared to Stretching on Hamstring Flexibility

Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study

Lithium Water in Gun Violence Prevention

Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure

Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department

Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO

Personalizing Preprocedural Sedation for Regional Anesthesia

Family Therapy as Hospital Aftercare for Adolescent Suicide Attempters

Gastric Ultrasound in Tube Fed Intubated Patients

Test-and-treat for Influenza in Homeless Shelters